18 / 30
Page 62
Notes:
Journal of Gastrointestinal & Digestive System | ISSN: 2161-069X | Volume: 8
&
&
October 29-30, 2018 | San Francisco, USA
International Conference on
Gastrointestinal Cancer and Therapeutics
4
th
World Congress on
Digestive & Metabolic Diseases
26
th
Annual Congress on
Cancer Science and Targeted Therapies
Anabolics in the diagnosis and treatment of small intestinal bacterial overgrowth
Edward Lichten
Wayne State University School of Medicine, USA
F
ollowing on the footsteps of Marshall who discovered
H. pylori
and the presumed relationship to peptic ulcer, Pimentel and
others thought they had found a methane-producing bacteria that was instrumental in the disabling pain, gas, diarrhea, and
disability that they named SIBO: small intestinal bacterial overgrowth. The non-absorbable rifaximin became a billion-dollar
product, while, the literature not only questioned any scientific methodology but also, if any patients have symptoms relief for
more than 12 weeks. A thorough hormonal, breathe gas analysis and work up for gastrointestinal disorders was undertaken on
20 patients, half who had been seen, treated at least twice, and failed in consultation with even Pimentel himself. Correcting the
underlying hormonal dysregulation was successful in relieving symptoms in 75% of the two-thirds followed for one year. None
needed the antibiotics while a minority of 4 did well with nutraceuticals. Two-thirds resumed a normal life. Interestingly, this
gastrointestinal disorder had a high incidence of autoimmunity: pernicious anemia, atrophic gastritis, Hashimoto’s thyroiditis,
and inflammatory serum markers. In summary, the use of the biomarker, the Free Androgen Index, was effective in defining
the hormonal disruption that when corrected, corrected the vast majority of men and women ’s with major SIBO complaints.
Tests for intestinal permeability, methane and hydrogen gas breathe tests, tests for celiac and
H. pylori
were in these 20 patients
of no value. SIBO is another autoimmune, inflammatory hormonal dysregulation disease that can be simply diagnosed and
treated by recognizing the hormonal, Gender-Specific cause.
Biography
Edward Lichten is an obstetrician-gynecologist in Birmingham, Michigan and is affiliated with multiple hospitals in the area, including DMC Huron Valley-Sinai
Hospital and Providence-Providence Park Hospitals. He received his medical degree from The Ohio State University College of Medicine and has been in practice
for more than 20 years. He is one of 39 doctors at DMC Huron Valley-Sinai Hospital and one of 73 at Providence-Providence Park Hospitals which were specialized
in Obstetrics and Gynecology.
dr.lichten@yahoo.comEdward Lichten, J Gastrointest Dig Syst 2018, Volume 8
DOI: 10.4172/2161-069X-C8-085